The dipeptidyl peptidase family, prolyl oligopeptidase, and prolyl carboxypeptidase in the immune system and inflammatory disease, including atherosclerosis
Y Waumans, L Baerts, K Kehoe, AM Lambeir… - Frontiers in …, 2015 - frontiersin.org
Research from over the past 20 years has implicated dipeptidyl peptidase (DPP) IV and its
family members in many processes and different pathologies of the immune system. Most …
family members in many processes and different pathologies of the immune system. Most …
Human proline specific peptidases: A comprehensive analysis
YE Dunaevsky, VF Tereshchenkova, B Oppert… - … et Biophysica Acta (BBA …, 2020 - Elsevier
Abstract Background Proline specific peptidases (PSPs) are a unique group of enzymes that
specifically cleave bonds formed by a proline residue. The study of PSPs is important due to …
specifically cleave bonds formed by a proline residue. The study of PSPs is important due to …
Extended structure–activity relationship and pharmacokinetic investigation of (4-quinolinoyl) glycyl-2-cyanopyrrolidine inhibitors of fibroblast activation protein (FAP)
K Jansen, L Heirbaut, R Verkerk… - Journal of medicinal …, 2014 - ACS Publications
Fibroblast activation protein (FAP) is a serine protease related to dipeptidyl peptidase IV
(DPPIV). It has been convincingly linked to multiple disease states involving remodeling of …
(DPPIV). It has been convincingly linked to multiple disease states involving remodeling of …
Experience-dependent plasticity in an innate social behavior is mediated by hypothalamic LTP
S Stagkourakis, G Spigolon, G Liu… - Proceedings of the …, 2020 - pnas.org
All animals can perform certain survival behaviors without prior experience, suggesting a
“hard wiring” of underlying neural circuits. Experience, however, can alter the expression of …
“hard wiring” of underlying neural circuits. Experience, however, can alter the expression of …
Environmental enrichment attenuates behavioral abnormalities in valproic acid-exposed autism model mice
We recently demonstrated that prenatal exposure to valproic acid (VPA) at embryonic day
12.5 causes autism spectrum disorder (ASD)-like phenotypes such as hypolocomotion …
12.5 causes autism spectrum disorder (ASD)-like phenotypes such as hypolocomotion …
Preclinical development of PNT6555, a boronic acid–based, fibroblast activation protein-α (FAP)–targeted radiotheranostic for imaging and treatment of FAP-positive …
SE Poplawski, RM Hallett, MH Dornan… - Journal of Nuclear …, 2024 - jnm.snmjournals.org
The overexpression of fibroblast activation protein-α (FAP) in solid cancers relative to levels
in normal tissues has led to its recognition as a target for delivering agents directly to tumors …
in normal tissues has led to its recognition as a target for delivering agents directly to tumors …
Mechanism of action of prolyl oligopeptidase (PREP) in degenerative brain diseases: has peptidase activity only a modulatory role on the interactions of PREP with …
PT Männistö, JA García-Horsman - Frontiers in aging neuroscience, 2017 - frontiersin.org
In the aging brain, the correct balance of neural transmission and its regulation is of
particular significance, and neuropeptides have a significant role. Prolyl oligopeptidase …
particular significance, and neuropeptides have a significant role. Prolyl oligopeptidase …
The biological role of prolyl oligopeptidase and the procognitive potential of its peptidic inhibitors from food proteins
A Taraszkiewicz, I Sinkiewicz, A Sommer… - Critical Reviews in …, 2024 - Taylor & Francis
Prolyl oligopeptidase (POP) is a conserved serine protease belonging to proline-specific
peptidases. It has both enzymatic and non-enzymatic activity and is involved in numerous …
peptidases. It has both enzymatic and non-enzymatic activity and is involved in numerous …
Multiomics Analyses Identify Proline Endopeptidase–Like Protein As a Key Regulator of Protein Trafficking, a Pathway Underlying Alzheimer's Disease Pathogenesis
Current treatments for Alzheimer's disease (AD) help reduce symptoms for a limited time but
do not treat the underlying pathology. To identify potential therapeutic targets for AD, an …
do not treat the underlying pathology. To identify potential therapeutic targets for AD, an …
Presynaptic congenital myasthenic syndromes: understanding clinical phenotypes through in vivo models
A Pugliese, SH Holland, C Rodolico… - Journal of …, 2023 - content.iospress.com
Presynaptic congenital myasthenic syndromes (CMS) are a group of genetic disorders
affecting the presynaptic side of the neuromuscular junctions (NMJ). They can result from a …
affecting the presynaptic side of the neuromuscular junctions (NMJ). They can result from a …